Triple
T686644
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Food and Drug Administration |
E13297
|
entity |
| Predicate | hasDivision |
P35
|
FINISHED |
| Object |
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
|
E85252
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Drug Evaluation and Research | Statement: [Food and Drug Administration, hasDivision, Center for Drug Evaluation and Research]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Center for Drug Evaluation and Research Context triple: [Food and Drug Administration, hasDivision, Center for Drug Evaluation and Research]
-
A.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Office of Research and Development
The Office of Research and Development is a specialized unit focused on planning, funding, and overseeing scientific and technological research initiatives within its parent organization.
-
E.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Center for Drug Evaluation and Research Triple: [Food and Drug Administration, hasDivision, Center for Drug Evaluation and Research]
Generated description
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Center for Drug Evaluation and Research Target entity description: The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
A.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Office of Research and Development
The Office of Research and Development is a specialized unit focused on planning, funding, and overseeing scientific and technological research initiatives within its parent organization.
-
E.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4933e0f98819097d22766c49b61b8 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a4a093ac988190bb339616a3ed5adb |
completed | March 1, 2026, 8:24 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a5dca352248190a3e1b4e4c58a1e7f |
completed | March 2, 2026, 6:53 p.m. |
| NEDg | Description generation | batch_69a5dd2e39808190ab116593299a94f8 |
completed | March 2, 2026, 6:55 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a5fe3bb2a08190a01ce2ed8b52ee4a |
completed | March 2, 2026, 9:16 p.m. |
Created at: March 1, 2026, 7:36 p.m.